Products

What will AGI do for Amsacrine?

This classification denotes an intercalating agent with the molecular formula C21H19N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00DPD30SOY, chemically known as methansulfon-m-aniside, 4-(9-acridinylamino)-, monohydrochloride but generally known as amsacrine, which bears US NIH Compound Identifier 2179. Amsacrine most often comes in hydrochloride and lactate forms. European Medicines Agency schedules Amsacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05495MIG. The term AMSACRINE is an International Non-Proprietary Name. World Health Organization schedules amsacrine in its Anatomical Therapeutic Chemical (ATC) Classification. AMSACRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amsacrine under HS 29350090 and SITC 51580. As of Q4 2014, AMSACRINE remains the US FDA Preferred Term for this commodity. Amsacrine bears US NLM identifiers UMLS ID C0591085 and NCI Concept Code C240. SMILES: S(=O)(=O)(NC1CC(OC)C(NC2C3C(NC4C2CCCC4)CCCC3)CC1)C.